Compile Data Set for Download or QSAR
Report error Found 34 Enz. Inhib. hit(s) with all data for entry = 10716
TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561951(US11396495, No. 6 | 6-[(Z)-2-(aminomethyl)-3-fluor...)
Affinity DataIC50: 0.0400nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561952(US11396495, No. 7 | 6-[(E)-2-(aminomethyl)-3-fluor...)
Affinity DataIC50: 0.0900nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561958(US11396495, No. 13 | ethyl 2-[6-[(Z)-2-(aminomethy...)
Affinity DataIC50: 0.110nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561957(US11396495, No. 12 | ethyl 2-[6-[(E)-2-(aminomethy...)
Affinity DataIC50: 0.140nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561959(US11396495, No. 16 | 6-[(E)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 0.220nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561955(US11396495, No. 10 | 6-[(E)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 0.220nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561953(US11396495, No. 8 | 6-[(E)-2-(aminomethyl)-3-fluor...)
Affinity DataIC50: 0.320nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561950(US11396495, No. 5 | 6-[(E)-2-(aminomethyl)-3-fluor...)
Affinity DataIC50: 0.370nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561961(US11396495, No. 18 | 6-[(E)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 0.480nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561971(US11396495, No. 39 | 4-[6-[(Z)-2-(aminomethyl)-3-f...)
Affinity DataIC50: 0.530nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561960(US11396495, No. 17 | 6-[(Z)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 0.580nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561954(US11396495, No. 9 | 6-[(Z)-2-(aminomethyl)-3-fluor...)
Affinity DataIC50: 0.610nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561973(US11396495, No. 41 | 6-[(Z)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 0.630nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561970(US11396495, No. 38 | 4-[6-[(E)-2-(aminomethyl)-3-f...)
Affinity DataIC50: 0.680nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561975(US11396495, No. 43 | 6-[(Z)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 0.710nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561969(US11396495, No. 35 | 6-[(Z)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 0.710nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561966(US11396495, No. 29 | 6-[(Z)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 0.770nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561956(US11396495, No. 11 | 6-[(Z)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 0.820nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561978(US11396495, No. 55 | 6-[(Z)-2-[(aminomethyl)-3-flu...)
Affinity DataIC50: 0.820nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561963(US11396495, No. 21 | 6-[(Z)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 0.910nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561972(US11396495, No. 40 | 6-[(E)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 1nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561962(US11396495, No. 19 | 6-[(Z)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 1nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561842(US11396495, No. 2 | 7-[(Z)-2-(aminomethyl)-3-fluor...)
Affinity DataIC50: 1.01nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561976(US11396495, No. 53 | (Z)-3-fluoro-2-[(2-phenyl-3,4...)
Affinity DataIC50: 1.04nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561974(US11396495, No. 42 | 6-[(E)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 1.13nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561968(US11396495, No. 34 | 6-[(E)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 1.16nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561964(US11396495, No. 24 | 6-[(E)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 1.16nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561981(US11396495, No. 58 | methyl 2-[6-[(E)-2-(aminometh...)
Affinity DataIC50: 1.17nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561980(US11396495, No. 57 | methyl 3-[6-[(Z)-2-(aminometh...)
Affinity DataIC50: 1.27nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561982(US11396495, No. 59 | methyl 2-[6-[(Z)-2-(aminometh...)
Affinity DataIC50: 1.30nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561977(US11396495, No. 54 | 6-[(E)-2-[(aminomethyl)-3-flu...)
Affinity DataIC50: 1.44nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561965(US11396495, No. 28 | 6-[(E)-2-(aminomethyl)-3-fluo...)
Affinity DataIC50: 1.53nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561979(US11396495, No. 56 | methyl 3-[6-[(E)-2-(aminometh...)
Affinity DataIC50: 1.91nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM561967(US11396495, No. 33 | (E)-2-[(1,1-dioxo-3,4-dihydro...)
Affinity DataIC50: 1.98nMAssay Description:1. Determination of Inhibitory Activity of Human Recombinant SSAO/VAP-1Test purpose: The following methods can be used to determine the inhibitory ac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
Go to US Patent